LISPI, MONICA
 Distribuzione geografica
Continente #
AS - Asia 1.637
NA - Nord America 1.620
EU - Europa 845
SA - Sud America 236
AF - Africa 45
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.400
Nazione #
US - Stati Uniti d'America 1.575
SG - Singapore 516
CN - Cina 472
IT - Italia 212
VN - Vietnam 210
HK - Hong Kong 191
BR - Brasile 175
SE - Svezia 140
GB - Regno Unito 129
RU - Federazione Russa 92
KR - Corea 73
DE - Germania 69
ID - Indonesia 49
FI - Finlandia 39
FR - Francia 37
IN - India 28
AR - Argentina 24
CA - Canada 23
NL - Olanda 18
MA - Marocco 16
AU - Australia 14
JP - Giappone 13
AT - Austria 12
LT - Lituania 12
MX - Messico 12
UA - Ucraina 12
BD - Bangladesh 11
DK - Danimarca 10
ES - Italia 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
CL - Cile 8
PK - Pakistan 8
PL - Polonia 8
TR - Turchia 8
BE - Belgio 7
DZ - Algeria 7
EC - Ecuador 7
PH - Filippine 7
PY - Paraguay 7
ZA - Sudafrica 7
BG - Bulgaria 6
CO - Colombia 6
CZ - Repubblica Ceca 6
IE - Irlanda 6
MY - Malesia 6
UZ - Uzbekistan 6
IQ - Iraq 5
TH - Thailandia 5
TN - Tunisia 5
VE - Venezuela 5
JM - Giamaica 4
KE - Kenya 4
GR - Grecia 3
KZ - Kazakistan 3
NP - Nepal 3
RO - Romania 3
TW - Taiwan 3
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
IL - Israele 2
PT - Portogallo 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BY - Bielorussia 1
GE - Georgia 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
ML - Mali 1
NO - Norvegia 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.400
Città #
Singapore 361
Santa Clara 293
Ashburn 209
Hefei 205
Hong Kong 187
San Jose 114
Fairfield 92
Beijing 85
Council Bluffs 67
Nyköping 67
Seoul 67
Ho Chi Minh City 66
London 65
The Dalles 54
Hanoi 51
Chandler 44
Los Angeles 42
Chicago 37
Jakarta 36
Woodbridge 36
Helsinki 31
Houston 31
New York 28
Southend 28
Ann Arbor 27
Seattle 26
Cambridge 24
Milan 24
Wilmington 24
Salt Lake City 21
São Paulo 18
Lauterbourg 17
Modena 17
Moscow 17
Munich 16
Rome 16
Kent 14
San Diego 14
Orem 13
Bremen 12
Princeton 12
Phoenix 11
Copenhagen 10
Jacksonville 10
Shanghai 10
Boardman 9
Elk Grove Village 9
Settat 9
Buffalo 8
Manchester 8
Montreal 8
Naples 8
Napoli 8
Tokyo 8
Warsaw 8
Zurich 8
Amsterdam 7
Chennai 7
Genoa 7
Haiphong 7
Ninh Bình 7
Potenza 7
Sydney 7
Tampa 7
Atlanta 6
Bologna 6
Brooklyn 6
Da Nang 6
Darmstadt 6
Dublin 6
Guangzhou 6
Paris 6
Parma 6
Sofia 6
Brasília 5
Brno 5
Brussels 5
Dallas 5
Kilburn 5
Lappeenranta 5
Melbourne 5
Porto Alegre 5
Redondo Beach 5
Biên Hòa 4
Dearborn 4
Frankfurt am Main 4
Hải Dương 4
Johannesburg 4
Mitchell/Ontario 4
Nairobi 4
Phủ Lý 4
Quezon City 4
St Petersburg 4
Tashkent 4
Thái Bình 4
Asunción 3
Bangkok 3
Barnet 3
Belo Horizonte 3
Berrechid 3
Totale 2.964
Nome #
LH and hCG Action on the Same Receptor Results in Quantitatively and Qualitatively Different Intracellular Signalling 401
Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival 282
Gene Expression and Apoptosis Levels in Cumulus Cells of Patients with Polymorphisms of FSHR and LHB Undergoing in Vitro Fertilization Program 270
LH increases the response to FSH in granulosa-lutein cells from sub/poor-responder patients in vitro 244
Comparative assessment of the structural features of human follicle-stimulating hormone in products from multiple markets 200
Exploring the human chorionic gonadotropin induced steroid secretion profile of mouse Leydig tumor cell line 1 by a 20 steroid LC-MS/MS panel 188
Online comment by Batista et al. regarding article “Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection" 181
Testosterone Serum Levels Are Related to Sperm DNA Fragmentation Index Reduction after FSH Administration in Males with Idiopathic Infertility 175
Azione delle Gonadotropine sulle cellule target e relativa azione farmacologica nell'infertilità maschile: è tempo per l'azienda farmaceutica di cogliere la sfida? 169
Reduced FSH and LH action: implications for medically assisted reproduction 168
Letter to the editor in response to 'A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose' by P. Barrière, S. Hamamah, E. Arbo, C. Avril, B. Salle, J.-L. Pouly, et al. (J Gynecol Obstet Hum Reprod. 2023;52(1):102510) 166
Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis 158
Comparative Assessment of the Structural Features of Originator Recombinant Human Follitropin Alfa Versus Recombinant Human Follitropin Alfa Biosimilar Preparations Approved in Non-European Regions 150
In-depth glycosylation profiling of r-hFSH- α and r-hFSH- δ in comparison to human pituitary Follicle Stimulating Hormone 148
Biological Assay to Determine Gonadotropin Potency: From In Vivo to In Vitro Sustainable Method 141
Cost-effectiveness analysis of recombinant human follicle-stimulating hormone alfa(r-hFSH) and urinary highly purified menopausal gonadotropin (hMG) based on data from a large German registry 141
Comparison between follitropin-delta and follitropin-alfa for ovarian stimulation in context of ART is only scientifically sound and clinically relevant if individualization of starting dose is allowed in both arms! 138
Follicle-Stimulating Hormone Biological Products: Does Potency Predict Clinical Efficacy? 137
P-635 The impact of force-degraded variants of recombinant human follicle stimulating hormone alfa (r-hFSH alfa) on in-vitro and in-vivo biological activity 134
Treatment algorithms for high responders: What we can learn from randomized controlled trials, real-world data and models 134
Dosing Characteristics of Recombinant Human Luteinizing Hormone or Human Menopausal Gonadotrophin-Derived LH Activity in Patients Undergoing Ovarian Stimulation: A German Fertility Database Study 131
P-598 Dose accuracy of the follitropin-alfa, follitropin-alfa/lutropin-alfa and choriogonadotropin-alfa pen injectors used for fertility treatment 130
Use of a recombinant human follicle-stimulating hormone:recombinant human luteinizing hormone (r-hFSH:r-hLH) 2:1 combination for controlled ovarian stimulation during assisted reproductive technology treatment: A real-world study of routine practice in the Russian Federation 122
Trafficking of luteinizing hormone receptor directs the differential signal activation between luteinizing hormone and chorionic gonadotropin 121
Economic evaluation of Medically Assisted Reproduction: An educational overview of methods and applications for healthcare professionals 116
Correction: Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis (Reproductive Biology and Endocrinology, (2021), 19, 1, (51), 10.1186/s12958-021-00727-y) 110
Totale 4.455
Categoria #
all - tutte 19.621
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.621


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 0 0 0 0 11 8
2021/2022247 17 13 19 3 4 6 3 6 4 77 38 57
2022/2023252 29 46 20 9 23 20 8 20 23 8 14 32
2023/2024393 6 11 22 52 46 27 62 48 27 18 17 57
2024/20251.250 35 6 64 68 201 249 70 60 108 43 179 167
2025/20262.045 150 127 227 264 244 112 294 116 249 213 49 0
Totale 4.455